CClinicalTrials.gg
Active, not recruitingNCT06028880Free2BeUpdated Sep 13, 2023

Affirmative Mindfulness, Acceptance, and Compassion-based Intervention for SM

An interventional study of Free2Be in Minority Stress, sponsored by University of Coimbra. Active, not recruiting at 2 sites in Portugal. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-13.

Sponsored by University of Coimbra · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Oct 2023, 2 years 11 months ago, but the record still lists the study as active, not recruiting.
  • Registered 7 months after the study started (first participant enrolled Jan 2023, registered Aug 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this pilot clinical trial is to explore the effectiveness of Free2Be group intervention for sexual minorities. The main questions it aims to answer are:

  • Is it Free2Be effective in the decrease of stress?
  • Are mindfulness, acceptance, and self-compassion responsible for changes in psychological symptoms?

Participants will receive an affirmative mindfulness, acceptance, and self-compassion-based face-to-face group intervention with 13 weekly sessions (Free2Be).

Read the detailed description

Sexual Minorized (SM) individuals include several self-identified nonheterosexual sexual orientations. This population face uncountable forms of discrimination stemming from social stigma. Unsurprisingly, levels of psychopathology are poorer in SM individuals when compared to heterosexual individuals, The Minority Stress Model describes stress processes that help to explain this disparity, for example, expectations of rejection and internalized stigma. Beyond the specific minority-related processes, general maladaptive psychological processes also contribute to the elevated risk of psychopathology in this population (Psychological Mediation Framework), for example, self-criticism. Additionally, shame and fears of compassion seem to affect the mental health in this population.

When SM individuals try to access mental health care, they find inappropriate and discriminatory services with professionals without specific training on sexuality-related themes. Affirmative interventions are wide approaches with a positive and respectful perspective about sexual orientations, recognizing different identities as representations of human diversity. This approach identifies negative consequences in mental health as consequences of stress related to heterosexism, discrimination and violence against SM individuals.

Previous studies reinforcing the relevance of mindfulness, acceptance, and self-compassion as positive psychological processes for SM individuals. Free2Be was the first affirmative intervention based on mindfulness, acceptance, and compassion techniques for SM individuals, and is a manualized 13 weeks, face-to-face group intervention. The feasibility results highlighted the acceptability of this intervention, suggested some changes in the intervention content, and concluded about the viability of a pilot study.

02

Conditions studied

  • Minority Stress

Keywords

  • Affirmative group intervention
  • Sexual Minorities
  • mindfulness
  • acceptance
  • compassion
  • stress
  • minority stress
03

In context

Lead sponsor

University of Coimbra is the lead sponsor of 84 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Majority (> 18 years old)
  • Nonheterosexual self-identified
  • Being Portuguese
  • Perfectly understanding of Portuguese oral and written language
  • Gave informed and free consent

Exclusion criteria

Exclusion Criteria:

  • Currently receiving individual or group psychotherapy
  • Major Depressive Disorder - severe specifier
  • Hypo/maniac Episode - without full remission
  • Psychosis Characteristics in the last two months
  • Social impairment from Substance Use Disorder
  • High suicide risk (according to the Suicide Risk Index).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
28 participants (estimated)

Study arms

  • Experimental
    Experimental group

    1 pre-session + 12 sessions

    Behavioral: Free2Be

Interventions

  • BehavioralFree2Be

    Free2Be is a manualized 13-week face-to-face group intervention for SM individuals with one pre-session and plus 12 intervention sessions. The themes of each session are: Human nature \& Relation with suffering (S1), Emotional regulation \& Multiple selves (S2), Creative hopelessness \& Values (S3), Compassionate attention (S4), Compassionate acceptance (S5), Self-criticism; Compassion \& Flows of compassion (S6), Compassionate imagination; Compassionate self (S7), Early experiences; Stigma and shame; \& Compassionate cognitive desfusion (S8), Compassionate thinking (S9), Difficult emotions: Shame \& Anger (S10), Coming out \& Compassionate behaviour (assertiveness) (S11), Positive emotions \& Preparing for the future (S2).

06

What researchers measure

Primary outcomes

  1. Stress symptoms assessed by DASS-21

    The subscale Stress symptoms of the self-report Depression Anxiety Stress Scales (Lovibond \& Lovibond, 1995; Pais-Ribeiro et al., 2004) has 7 items that assess difficulties in relaxing, nervous excitement, agitation, exaggerated reactions, and impatience.

    Time frame: 6 months (from Baseline to 3-months follow-up)

Secondary outcomes

  1. Mindfulness assessed by CompACT-18

    The subscale Behavioural awareness of the self-report Comprehensive assessment of Acceptance and Commitment Therapy processes - 18 Items (CompACT-18; Francis et al., 2016; Trindade et al., 2021) has 5 items that assess mindful attention to the present moment.

    Time frame: 6 months (from Baseline to 3-months follow-up)

  2. Acceptance assessed by CompACT-18

    The subscale Openness to experience of the self-report Comprehensive assessment of Acceptance and Commitment Therapy processes - 18 Items (CompACT-18; Francis et al., 2016; Trindade et al., 2021) has 5 items that assess willingness to allow internal experiences without efforts to change it.

    Time frame: 6 months (from Baseline to 3-months follow-up)

  3. Self-compassion assessed by CMAS

    The Self-compassion scale of the self-report Compassion Motivation and Action Scales (CMAS; Steindl et al., 2021; Matos et al., 2023) has 18 items that assess the intent to be self-compassionate, distress tolerance during own suffering, and behaviours to alleviate this suffering.

    Time frame: 6 months (from Baseline to 3-months follow-up)

  4. Stigma consciousness assessed by SCQ-PT

    The self-report Stigma Consciousness Questionnaire (SCQ-PT; Pinel, 1999; Seabra, Gato, et al., 2023) has 10 items that assess the extent to which sexual minority individuals focus on feel self-conscious about their stereotyped status.

    Time frame: 6 months (from Baseline to 3-months follow-up)

  5. Internalized stigma assessed by LGBIS

    The subscale Identity dissatisfaction of the self-report Lesbian, Gay, Bisexual Identity Scale (LGBIS; Mohr \& Kendra, 2011; Oliveira et al., 2012) has 6 items that assess internalized stigma.

    Time frame: 6 months (from Baseline to 3-months follow-up)

  6. Shame assessed by SMEISS

    The Sexual Minority External and Internal Shame Scale (Manão et al., 2023) has 8 items that assess shame related to sexual orientation.

    Time frame: 6 months (from Baseline to 3-months follow-up)

  7. Self-Criticism assessed by FSCRS

    The composite measure of Inadequate self and Hated self of the self-report Forms of Self-criticizing/Attacking and Self-reassuring Scale (FSCRS; Gilbert et al., 2004; Castilho et al., 2015) has 14 items that assess the experience of inadequacy and self-dislike when failures and setbacks occur. The use of this composite measure is very common in the assessment of self-criticism. Recent years research in non-clinical samples has favoured a unique global factor of self-criticism considering Inadequate self and Hated self together (Halamová et al., 2019).

    Time frame: 6 months (from Baseline to 3-months follow-up)

  8. Fears of compassion for other assessed by FCS

    The subscale Fear of compassion to others of the self-report Fears of Compassion Scale (FCS; Gilbert et al., 2011; Simões, 2012) has 10 items that assess fears, blocks, and resistances to giving compassion to others.

    Time frame: 6 months (from Baseline to 3-months follow-up)

  9. Fears of compassion from other assessed by FCS

    The subscale Fear of compassion from others of the self-report Fears of Compassion Scale (FCS; Gilbert et al., 2011; Simões, 2012) has 13 items that assess fears, blocks, and resistances to receive compassion.

    Time frame: 6 months (from Baseline to 3-months follow-up)

  10. Fears of self-compassion assessed by FCS

    The subscale Fear for compassion for self of the self-report Fears of Compassion Scale (FCS; Gilbert et al., 2011; Simões, 2012) has 15 items that assess one's fears, blocks, and resistances to self-compassion.

    Time frame: 6 months (from Baseline to 3-months follow-up)

  11. Anxiety symptoms assessed by DASS-21

    The subscale Anxiety symptoms of the self-report Depression Anxiety Stress Scales (Lovibond \& Lovibond, 1995; Pais-Ribeiro et al., 2004) has 7 items that assess physical arousal symptoms, panic attacks, and fear.

    Time frame: 6 months (from Baseline to 3-months follow-up)

  12. Depressive symptoms assessed by DASS-21

    The subscale Depression symptoms of the self-report Depression Anxiety Stress Scales (Lovibond \& Lovibond, 1995; Pais-Ribeiro et al., 2004) has 7 items that assess symptoms usually associated with negative mood.

    Time frame: 6 months (from Baseline to 3-months follow-up)

  13. Social anxiety symptoms assessed by SIAS

    The self-report Social Interaction Anxiety Scale (SIAS; Mattick \& Clarke, 1998; Pinto-Gouveia \& Salvador, 2001) has 19 items that assess fears of general social interaction.

    Time frame: 6 months (from Baseline to 3-months follow-up)

  14. Positive affect (drive system) assessed by ASCAS

    The composite measure of Activated positive affect and Relaxed positive affect of the self-report Activation and Safe/Content Affect Scale (ASCAS; Gilbert et al., 2008; Pinto-Gouveia et al., 2008) has 14 items that assess the experience of positive affect associated to resource acquisitions and achievements. This composite measure aligns with theorical affect regulation systems (Gilbert, 2010).

    Time frame: 6 months (from Baseline to 3-months follow-up)

  15. Positive affect (soothing system) assessed by ASCAS

    The subscale Safe/content positive affect of the self-report Activation and Safe/Content Affect Scale (ASCAS; Gilbert et al., 2008; Pinto-Gouveia et al., 2008) has 4 items that assess the experience of positive affect associated to safeness, caring, and contentment.

    Time frame: 6 months (from Baseline to 3-months follow-up)

  16. Negative affect (threat system) assessed by PANAS

    The subscale Negative affect of the self-report Positive and Negative Affect Schedule (PANAS; Watson, Clark \& Tellegen, 1988; Galinha \& Pais-Ribeiro, 2005) has 10 items that assess the experience of positive affect associated to detection and protection.

    Time frame: 6 months (from Baseline to 3-months follow-up)

07

Study locations

2 sites
  • Faculty of Psychology and Educational Science
    Coimbra, 3000-115, Portugal
  • Serviços De Acção Social Da Universidade De Coimbra
    Coimbra, 3000-504, Portugal
08

References and documents

Publications

  • Pachankis JE. Uncovering Clinical Principles and Techniques to Address Minority Stress, Mental Health, and Related Health Risks Among Gay and Bisexual Men. Clin Psychol (New York). 2014 Dec;21(4):313-330. doi: 10.1111/cpsp.12078. PubMed 25554721 ↗
  • Helminen EC, Ducar DM, Scheer JR, Parke KL, Morton ML, Felver JC. Self-Compassion, Minority Stress, and Mental Health in Sexual and Gender Minority Populations: A Meta-Analysis and Systematic Review. Clin Psychol (New York). 2023 Mar;30(1):26-39. doi: 10.1037/cps0000104. Epub 2022 Nov 28. PubMed 37197599 ↗
  • Fowler JA, Buckley L, Muir M, Viskovich S, Paradisis C, Zanganeh P, Dean JA. Digital mental health interventions: A narrative review of what is important from the perspective of LGBTQIA+ people. J Clin Psychol. 2023 Nov;79(11):2685-2713. doi: 10.1002/jclp.23571. Epub 2023 Aug 2. PubMed 37528773 ↗
  • Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull. 2003 Sep;129(5):674-697. doi: 10.1037/0033-2909.129.5.674. PubMed 12956539 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06028880
Lead sponsor
University of Coimbra
Responsible party
Daniel Seabra (Daniel Seabra (Principal Investigator), University of Coimbra) — Principal investigator
First posted
Sep 8, 2023
Start date
Jan 1, 2023
Primary completion
Oct 31, 2023 (estimated)
Completion
Oct 31, 2023 (estimated)
Last update
Sep 13, 2023

Study contacts

Daniel Seabra
principal investigator · University of Coimbra

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion